Φορτώνει......
Pretargeting for imaging and therapy in oncological nuclear medicine
BACKGROUND: Oncological pretargeting has been implemented and tested in several different ways in preclinical models and clinical trials over more than 30 years. Despite highly promising results, pretargeting has not achieved market approval even though it could be considered the ultimate theranosti...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | EJNMMI Radiopharm Chem |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer International Publishing
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5824696/ https://ncbi.nlm.nih.gov/pubmed/29503847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41181-017-0026-8 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|